SOD1

Assets acting on this target.

Class
SOD1 mRNA-lowering oligonucleotide (antisense or RNAi)
Notes
mechanism wave 2026-08-24 (DeepSeek draft; registry text of NCT06351592 names the target); source: https://clinicaltrials.gov/study/NCT06351592

By indication

SOD1 drugs compared

2 drugs, stage by indication
2 drugs acting on SOD1: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
TofersenQalsodyBiogen, Ionis PharmaceuticalsantisenseApprovedApproved in Amyotrophic Lateral Sclerosis
ALN-SODRegeneron PharmaceuticalsRNAi (siRNA)Phase 1/2Phase 1/2 in Amyotrophic Lateral Sclerosis

← all mechanisms